Sensei Biotherapeutics, Inc. (SNSE) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$28.26
Day's range
$30.55

Sensei Biotherapeutics Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
SUVRETTA CAPITAL MANAGEMENT, LLC 08/14/2026 2.02 M $50.50 M   5,747.07% 35.80%
AVORO CAPITAL ADVISORS LLC 08/14/2026 1.44 M $36.10 M   100.00% 25.59%
BAKER BROS. ADVISORS LP 08/14/2026 1.29 M $32.16 M   100.00% 22.80%
BALYASNY ASSET MANAGEMENT L.P. 08/14/2026 1.04 M $26.05 M   6,331.34% 18.47%
CORMORANT ASSET MANAGEMENT, LP 08/14/2026 1.03 M $7.66 M   235.78% 18.22%
RA CAPITAL MANAGEMENT, L.P. 08/14/2026 722.02 K $18.05 M   100.00% 12.79%
VIVO CAPITAL, LLC 08/14/2026 722.02 K $18.05 M   0.00% 12.79%
LOGOS GLOBAL MANAGEMENT LP 08/14/2026 722.02 K $18.05 M   2,306.73% 12.79%
FAIRMOUNT FUNDS MANAGEMENT LLC 08/14/2026 722.02 K $18.05 M   100.00% 12.79%
CALIGAN PARTNERS LP 08/14/2026 629.47 K $15.74 M   399.57% 11.15%
B GROUP, INC. 08/14/2026 610.17 K $15.25 M   100.00% 10.81%
TRAILS EDGE CAPITAL PARTNERS, LP 08/14/2026 515.34 K $12.88 M   312.27% 9.13%
FRANKLIN RESOURCES INC 08/13/2026 494.52 K $12.36 M   270.41% 8.76%
OCTAGON CAPITAL ADVISORS LP 08/14/2026 361.01 K $9.03 M   100.00% 6.40%
ADAR1 CAPITAL MANAGEMENT, LLC 08/14/2026 361.01 K $9.03 M   100.00% 6.40%
MARSHALL WACE, LLP 08/13/2026 206.51 K $5.16 M   214.18% 3.66%
BOXER CAPITAL MANAGEMENT, LLC 08/14/2026 180.51 K $4.51 M   100.00% 3.20%
PATIENT SQUARE CAPITAL LP 08/12/2026 175.05 K $4.38 M   100.00% 3.10%
ALYESKA INVESTMENT GROUP, L.P. 08/14/2026 144.40 K $3.61 M   100.00% 2.56%
AFFINITY ASSET ADVISORS, LLC 08/13/2026 144.40 K $3.61 M   100.00% 2.56%
BOOTHBAY FUND MANAGEMENT, LLC 08/14/2026 133.64 K $3.34 M   411.57% 2.37%
AWM INVESTMENT COMPANY, INC. 08/14/2026 111.34 K $2.78 M   100.00% 1.97%
RICHMOND INVESTMENT SERVICES, LLC 07/27/2026 79.73 K $1.99 M   100.00% 1.41%
IKARIAN CAPITAL, LLC 08/14/2026 35.39 K $884.65 K   457.17% 0.63%
UBS GROUP AG 08/13/2026 21.54 K $538.53 K   375.62% 0.38%
RENAISSANCE TECHNOLOGIES LLC 08/13/2026 20.42 K $510.40 K   -36.28% 0.36%
JANE STREET GROUP, LLC 08/14/2026 20.12 K $502.91 K   126.75% 0.36%
MORGAN STANLEY 08/13/2026 17.33 K $433.23 K   97.03% 0.31%
CATALIO CAPITAL MANAGEMENT, LP 08/14/2026 14.72 K $367.95 K   0.00% 0.26%
GEODE CAPITAL MANAGEMENT, LLC 08/12/2026 14.62 K $365.44 K   53.84% 0.26%
SUPERSTRING CAPITAL MANAGEMENT LP 08/14/2026 14.18 K $354.38 K   100.00% 0.25%
BARCLAYS PLC 08/14/2026 12.41 K $310.30 K   100.00% 0.22%
CITADEL ADVISORS LLC 09/02/2026 12.30 K $307.40 K   100.00% 0.22%
VANGUARD CAPITAL MANAGEMENT LLC 08/13/2026 10.12 K $252.88 K   30.52% 0.18%
XTX TOPCO LTD 08/14/2026 9.61 K $240.20 K   100.00% 0.17%
VANGUARD FIDUCIARY TRUST CO 08/13/2026 6.31 K $157.68 K   0.00% 0.11%
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. 07/24/2026 3.60 K $90.00 K   100.00% 0.06%
BLACKROCK, INC. 08/07/2026 3.40 K $85.05 K   100.00% 0.06%
TOWER RESEARCH CAPITAL LLC (TRC) 08/11/2026 650 $16.25 K   -56.55% 0.01%
ROYAL BANK OF CANADA 08/14/2026 509 $13.00 K   100.00% 0.01%
BNP PARIBAS ARBITRAGE, SNC 08/13/2026 113 $2.83 K   1,155.56% 0.00%
JPMORGAN CHASE & CO 08/12/2026 40 $929   25.00% 0.00%
QUARRY LP 08/14/2026 32 $800   100.00% 0.00%
PHYSICIAN WEALTH ADVISORS, INC. 07/20/2026 28 $700   100.00% 0.00%
SBI SECURITIES CO., LTD. 07/23/2026 4 $100   0.00% 0.00%
FRED ALGER MANAGEMENT, LLC 08/14/2026 0 $0   -100.00% 0.00%
BANK OF AMERICA CORP /DE/ 08/14/2026 0 $0   -100.00% 0.00%
GOLDMAN SACHS GROUP INC 08/14/2026 0 $0   -100.00% 0.00%
MILLENNIUM MANAGEMENT LLC 08/14/2026 0 $0   -100.00% 0.00%
HRT FINANCIAL LP 08/14/2026 0 $0   -100.00% 0.00%

Sensei Biotherapeutics Inc institutional Ownership - FAQ's

During the previous two years, 57 institutional investors and hedge funds held shares of Sensei Biotherapeutics Inc. The most heavily invested institutionals were:

SUVRETTA CAPITAL MANAGEMENT, LLC: 2.02 M

Avoro Capital Advisors LLC: 1.44 M

BAKER BROS. ADVISORS LP: 1.29 M

BALYASNY ASSET MANAGEMENT L.P.: 1.04 M

Cormorant Asset Management, LP: 1.03 M

RA CAPITAL MANAGEMENT, L.P.: 722,020

249.39% of Sensei Biotherapeutics Inc stock is owned by institutional investors.

Institutional investors have bought a total of 14.12 M shares in the last 24 months. This purchase volume represents approximately $416.50 M in transactions.